InsiderClue
Insiders · Profile

Geffner Michael

Chief Medical Officer at Immunovant. Filing since 26 Jan 2024. CIK 0002007249

Company
Date
Role
Action
Shares
Amount
Of holding
IMVT Immunovant, Inc.
22 Oct 2025
Chief Medical Officer
Sold at will
2,595
$49.38K
1.2%
IMVT Immunovant, Inc.
8 Oct 2025
Chief Medical Officer
Sold at will
1,272
$20.73K
0.6%
IMVT Immunovant, Inc.
23 Jul 2025
Chief Medical Officer
Sold at will
2,385
$43.29K
1.1%
IMVT Immunovant, Inc.
9 Jul 2025
Chief Medical Officer
Sold at will
1,160
$20.00K
0.5%
IMVT Immunovant, Inc.
23 Apr 2025
Chief Medical Officer
Sold at will
2,349
$34.74K
1.0%
IMVT Immunovant, Inc.
9 Apr 2025
Chief Medical Officer
Sold at will
6,169
$80.14K
2.6%
IMVT Immunovant, Inc.
22 Jan 2025
Chief Medical Officer
Sold at will
2,657
$62.68K
2.0%
IMVT Immunovant, Inc.
23 Oct 2024
Chief Medical Officer
Sold at will
3,189
$94.17K
2.3%
IMVT Immunovant, Inc.
24 Jul 2024
Chief Medical Officer
Sold at will
3,456
$95.94K
2.4%
IMVT Immunovant, Inc.
24 Apr 2024
Chief Medical Officer
Sold at will
3,261
$94.24K
2.3%
IMVT Immunovant, Inc.
26 Jan 2024
Chief Medical Officer
Sold at will
10,101
$383.01K
10.1%
11 decisions on file.